glp-1

Medications for Diabetes and Weight Loss May Increase Risk of Cognitive Impairment, New Study Warns

by

Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the treatment landscape for type 2 diabetes and obesity, offering significant benefits in blood sugar control and weight reduction. However, as their use expands globally, questions are emerging about potential long-term effects on brain health. Recent research suggests a complex relationship between these medications and cognitive function, warranting … Read more

Duodenal Mucosal Resurfacing: A Breakthrough in Weight Loss and Metabolic Health with GLP-1 Medications

by

Duodenal mucosal resurfacing (DMR), an investigational endoscopic procedure, has shown promise in helping patients maintain weight loss after discontinuing GLP-1 receptor agonist medications such as Ozempic and Wegovy, according to findings presented at Digestive Disease Week® (DDW) 2026. The minimally invasive technique, which uses hydrothermal ablation to renew the lining of the upper small intestine, … Read more

Ozempic & Oscars: Hollywood’s Weight Loss Trend Sparks Health & Ethical Concerns

by

The 98th Academy Awards, held recently in Hollywood, sparked a renewed debate about body image and the pressures faced by celebrities, with many observers noting a strikingly thin physique among several attendees. This has fueled speculation about the increasing use of weight-loss drugs, particularly Ozempic, within the entertainment industry. While the pursuit of a certain … Read more

Gut Health & Nordic Diet: How Barrier Integrity Impacts Metabolism

by

Berlin, Germany – The intricate relationship between our gut microbiome, diet, and overall health continues to be a focal point of medical research. While the concept of “feeding your gut” has gained widespread popularity, translating that into concrete, evidence-based recommendations remains a complex undertaking. Recent studies are increasingly highlighting the importance of gut barrier integrity … Read more

GLP-1 Drugs: Could ‘Weight Loss Injections’ Treat Multiple Addictions?

by

The burgeoning use of GLP-1 receptor agonists – initially developed to treat type 2 diabetes and obesity – is now attracting attention for a surprising potential benefit: reducing the risk of substance use disorders. Emerging research suggests these medications, including drugs like Ozempic and Mounjaro, may dampen cravings and reduce the likelihood of both fresh … Read more

>Blood Donation Rules Updated After Weight Loss Medication Use

by

2026-02-02 21:27:00 Primeira nota técnica após popularização das canetas reduz prazos e reforça cuidados com o doador Procedimento de doação de sangue no Hemosul. (Foto: Arquivo) O Ministério da Saúde publicou a primeira Nota Técnica sobre a doação de sangue por pessoas que utilizam os chamados medicamentos emagrecedores à base de agonistas do receptor de … Read more